Carregant...
Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions
[Image: see text] A lack of target specificity has greatly hindered the success of inhibitor development against matrix metalloproteinases (MMPs) for the treatment of various cancers. The MMP catalytic domains are highly conserved, whereas the hemopexin-like domains of MMPs are unique to each family...
Guardat en:
| Publicat a: | ACS Chem Biol |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American
Chemical
Society
2017
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697452/ https://ncbi.nlm.nih.gov/pubmed/28945333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.7b00758 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|